Literature DB >> 11282118

Fibroblast growth factor inhibits locomotor activity as well as feeding behavior of rats.

M Hotta1, H Kuriyama, K Arai, K Takano, T Shibasaki.   

Abstract

The effects of acute and chronic intracerebroventricular (i.c.v.) administration of basic fibroblast growth factor (bFGF) on behavior were examined in free-feeding rats. An i.c.v. injection of bFGF induced behavioral changes, such as an increase in resting and decreases in grooming, moving, and food intake at a dose of 20 or 50 ng. These effects appeared at 4-5 h and lasted at least 11 h after the injection. These changes, as well as inhibition of body weight gain, were also found during a 6-day period of chronic i.c.v. infusion of bFGF at a dose of 20 ng/h. These results indicate that bFGF as both bolus i.c.v. injection and chronic i.c.v. infusion inhibits not only feeding behavior but also locomotor activity in rats. It is suggested that the inhibitory effect of bFGF on food intake may be in part ascribed to the suppression of behavior by bFGF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282118     DOI: 10.1016/s0014-2999(01)00767-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms.

Authors:  Christopher J Lelliott; Andrea Ahnmark; Therese Admyre; Ingela Ahlstedt; Lorraine Irving; Feenagh Keyes; Laurel Patterson; Michael B Mumphrey; Mikael Bjursell; Tracy Gorman; Mohammad Bohlooly-Y; Andrew Buchanan; Paula Harrison; Tristan Vaughan; Hans-Rudolf Berthoud; Daniel Lindén
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

2.  Role of insulin and growth hormone/insulin-like growth factor-I signaling in lifespan extension: rodent longevity models for studying aging and calorie restriction.

Authors:  T Chiba; H Yamaza; I Shimokawa
Journal:  Curr Genomics       Date:  2007-11       Impact factor: 2.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.